![Curtis Rambaran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Curtis Rambaran
Technik-/Wissenschafts-/F&E-Leiter bei
SILENCE THERAPEUTICS PLC
Profil
Curtis Rambaran is currently Chief Medical Officer at Silence Therapeutics Plc since 2023.
Dr. Rambaran was Head-European Translational Medicine at Daiichi Sankyo UK Ltd. from 2016 to 2023.
Dr. Rambaran earned a doctorate from The University of the West Indies.
Aktive Positionen von Curtis Rambaran
| Unternehmen | Position | Beginn |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Ehemalige bekannte Positionen von Curtis Rambaran
| Unternehmen | Position | Ende |
|---|---|---|
Daiichi Sankyo UK Ltd.
 Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | 01.12.2023 |
Ausbildung von Curtis Rambaran
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
21
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
The University of the West Indies
 The University of the West Indies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
